(Q73371965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

decision support techniques

3 November 2019

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738453

31 December 2023

1

Sammy Saab

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Vincent DeRosa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jose Nieto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Francisco Durazo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Steven Han

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Bennett Roth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738453

31 December 2023

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://journals.lww.com/10.1111/j.1572-0241.2003.07392.x

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

The American Journal of Gastroenterology

31 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

763-770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

The treatment of portal hypertension: A meta-analytic review

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Natural history of cirrhotic patients with small esophageal varices: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Research guidelines for the Delphi survey technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Applying the Delphi technique in a study of GPs' information requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

MELD and PELD: application of survival models to liver allocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07392.X

Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study

31 December 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

31 December 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

31 December 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Screening for breast cancer

31 December 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

31 December 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment.

31 December 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

31 December 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial

31 December 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

31 December 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial.

31 December 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy

31 December 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis

31 December 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences

31 December 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Medical Assessment by a Delphi Group Opinion Technic

31 December 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

31 December 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C

31 December 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

31 December 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

The impact of age on the cost-effectiveness of hypertension treatment: an analysis of randomized drug trials.

31 December 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Survival and prognostic indicators in compensated and decompensated cirrhosis

31 December 2023

50

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

Compensated cirrhosis: Natural history and prognostic factors

31 December 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2003.07392.X

31 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738453%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference